BridgeMD
New treatment option for Gastric Insufflation
Official title Comparison of Gastric Insufflation Volume Between LarySeal Pro and Ambu AuraGain Using Ultrasonography In Pediatric Patients Undergoing General Anesthesia With Controlled Ventilation.
ClinicalTrials.gov ID: NCT07451470
What this study is testing
- What it's testing
- Gastric air insufflation during insertion of a laryngeal mask airway (LMA) is a known phenomenon and can have important clinical implications, especially in relation to: During positive pressure ventilation or improper insertion technique, air can be forced into the esophagus and stomach or LMAs do not fully seal the esophagus, so high ventilation pressures or incorrect placement may lead to gastric insufflation. Which may lead to Increased risk of regurgitation and aspiration, especially if the gastric contents reach the upper esophagus, Abdominal distension, which can reduce ventilation efficiency, nausea, vomiting, or delayed gastric emptying postoperatively which detected by Epigastric auscultation may reveal gurgling sounds during ventilation, Gastric ultrasound can visualize the extent of gastric insufflation and Capnography sometimes shows altered patterns if regurgitation begins .
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 10. Healthy volunteers may be eligible.
You may be able to join if
- Age: pediatrics (6-12years )
- Patients with a Mallampati score of I - II
- Elective surgeries
- Short procedure expected to last for 1 hour or less .
- ASA I - II
You likely can't join if
- Age: below 6 years and above 12 years
- Patient with airway masses
- Active upper respiratory tract infections, pneumonia, COPD \& exacerbated bronchial asthma.
- Patient with gastroesophgeal reflux ( hiatus hernia , achalasia )
- Patient with abnormal airway anatomy
- Coagulation disorders.
See the full eligibility criteria
- Age: pediatrics (6-12years )
- Patients with a Mallampati score of I - II
- Elective surgeries
- Short procedure expected to last for 1 hour or less .
- ASA I - II
- Age: below 6 years and above 12 years
- Patient with airway masses
- Active upper respiratory tract infections, pneumonia, COPD \& exacerbated bronchial asthma.
- Patient with gastroesophgeal reflux ( hiatus hernia , achalasia )
- Patient with abnormal airway anatomy
- Coagulation disorders.
- Patients with any cardiac conditions (IHD, RHD, decompensated heart failure and arrhythmia).
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 10 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.